N
Noriko Iwaki
Researcher at Kanazawa University
Publications - 40
Citations - 813
Noriko Iwaki is an academic researcher from Kanazawa University. The author has contributed to research in topics: Lymphoma & Medicine. The author has an hindex of 12, co-authored 34 publications receiving 588 citations. Previous affiliations of Noriko Iwaki include Okayama University.
Papers
More filters
Journal ArticleDOI
Clinicopathologic analysis of TAFRO syndrome demonstrates a distinct subtype of HHV-8-negative multicentric Castleman disease
Noriko Iwaki,David C. Fajgenbaum,Christopher S. Nabel,Yuka Gion,Eisei Kondo,Mitsuhiro Kawano,Taro Masunari,Isao Yoshida,Hiroshi Moro,Koji Nikkuni,Kazue Takai,Kosei Matsue,Mitsutoshi Kurosawa,Masao Hagihara,Akio Saito,Masataka Okamoto,Kenji Yokota,Shinichiro Hiraiwa,Naoya Nakamura,Shinji Nakao,Tadashi Yoshino,Yasuharu Sato +21 more
TL;DR: TAFRO syndrome is a unique subtype of iMCD that demonstrates characteristic clinicopathological findings and further study to clarify prognosis, pathophysiology, and appropriate treatment is needed.
Journal ArticleDOI
Clinicopathologic analysis of IgG4-related skin disease
Yasuharu Sato,Mai Takeuchi,Katsuyoshi Takata,Kyotaro Ohno,Noriko Iwaki,Yorihisa Orita,Naoe Goto,Akira I Hida,Toshiyuki Iwamoto,Naoko Asano,Toshihiro Ito,Hiroyuki Hanakawa,Hiroyuki Yanai,Tadashi Yoshino +13 more
TL;DR: In conclusion, patients with IgG4-related skin disease had uniform clinicopathology, and lesions were frequently present on the skin of the periauricular, cheek, and mandible regions, and were frequently accompanied by IgG 4-related lymphadenopathy.
Journal ArticleDOI
Atypical hyaline vascular-type castleman's disease with thrombocytopenia, anasarca, fever, and systemic lymphadenopathy.
Noriko Iwaki,Yasuharu Sato,Katsuyoshi Takata,Eisei Kondo,Kyotaro Ohno,Mai Takeuchi,Yorihisa Orita,Shinji Nakao,Tadashi Yoshino +8 more
TL;DR: The association of these atypical features with well-known multicentric Castleman's disease (MCD), namely, HV-type histology with systemic lymphadenopathy, marked thrombocytopenia even with a high level of interleukin-6, and increased acute inflammatory proteins without hyper-γ-globulinemia, suggests that TAFRO syndrome as presented in this case is a novel entity.
Journal ArticleDOI
Clinicopathological analysis of methotrexate-associated lymphoproliferative disorders: Comparison of diffuse large B-cell lymphoma and classical Hodgkin lymphoma types.
Yuka Gion,Noriko Iwaki,Katsuyoshi Takata,Mai Takeuchi,Keiichiro Nishida,Yorihisa Orita,Tomoyasu Tachibana,Tadashi Yoshino,Yasuharu Sato,Yasuharu Sato +9 more
TL;DR: The morphological differences in the pathological findings ofMTX‐LPD may be a factor for spontaneous or non‐spontaneous regression after discontinuation of MTX, and overall survival was not significantly different between DLBCL‐type and CHL‐ type.
Journal ArticleDOI
A multicenter, open-label, phase II study of tirabrutinib (ONO/GS-4059) in patients with Waldenström's macroglobulinemia.
Naohiro Sekiguchi,Shinya Rai,Wataru Munakata,Kenshi Suzuki,Hiroshi Handa,Hirohiko Shibayama,Tomoyuki Endo,Yasuhito Terui,Noriko Iwaki,Noriko Fukuhara,Hiro Tatetsu,Shinsuke Iida,Takayuki Ishikawa,Ryota Shiibashi,Koji Izutsu +14 more
TL;DR: Although the follow‐up duration was relatively short, the study met the primary endpoint and tirabrutinib monotherapy is considered to be highly effective for both untreated and relapsed/refractory WM with a manageable safety profile.